-
Parkinson’s Disease with Mild Cognitive Impairment Treated with a Nicotinic Agonist Drug
… scans obtained before and at end of treatment. Impact on Diagnosis/Treatment of Parkinson’s Disease: There is the … Research Grant …
-
Assessing Target Engagement for Terazosin
… six participants at differing doses of terazosin. Impact on Diagnosis/Treatment of Parkinson’s Disease: We believe that … Research Grant …
-
Safety and Tolerability of NLX-112 in People with Parkinson’s
… such as mood and sleep, will also be assessed. Impact on Diagnosis/Treatment of Parkinson’s Disease: If the trial is … Research Grant …
-
Alpha-synuclein Toxicity in LRRK2 Knock-in Models and Rescue by LRRK2 Silencing
… processes induced by alpha-synuclein PFFs. Impact on Diagnosis/Treatment of Parkinson’s Disease: LRRK2 silencing … Research Grant …
-
Codevelopment of Small-molecule Regulators of Miro1 for the Treatment of Parkinson’s Disease and a GLP Clinical Biomarker Assay
… of drug effect in the CNS of PD patients. Impact on Diagnosis/Treatment of Parkinson’s disease: This project … Research Grant …
-
Biomarker for Mitophagy Pathway Activation
… detection platforms and complementary assays. Impact on Diagnosis/Treatment of Parkinson’s Disease: We expect the … Research Grant …